These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20553063)

  • 1. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
    Bovenschen HJ; Langewouters AM; van de Kerkhof PC
    Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
    Bovenschen HJ; Gerritsen WJ; van Rens DW; Seyger MM; de Jong EM; van de Kerkhof PC
    Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study.
    Bovenschen HJ; Otero ME; Langewouters AM; van Vlijmen-Willems IM; van Rens DW; Seyger MM; van de Kerkhof PC
    Br J Dermatol; 2007 Feb; 156(2):263-70. PubMed ID: 17223865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
    Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.
    Vissers WH; van Duijnhoven M; van Erp PE; de Jong EM; van de Kerkhof PC
    J Dermatolog Treat; 2008; 19(6):344-50. PubMed ID: 19016104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation.
    Vissers WH; Roelofzen J; De Jong EM; Van Erp PE; Van de Kerkhof PC
    Eur J Dermatol; 2005; 15(1):13-7. PubMed ID: 15701587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies.
    van Lingen RG; Körver JE; van de Kerkhof PC; Berends MA; van Rens DW; Langewouters AM; Boezeman JB; Seyger MM; de Jong EM
    Br J Dermatol; 2008 Jul; 159(1):91-6. PubMed ID: 18476954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
    Bovenschen HJ; Vissers WH; Seyger MM; van de Kerkhof PC
    Acta Derm Venereol; 2005; 85(2):113-7. PubMed ID: 15823902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis.
    Smits T; Kleinpenning MM; van Erp PE; van de Kerkhof PC; Gerritsen MJ
    Br J Dermatol; 2006 Aug; 155(2):429-36. PubMed ID: 16882185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept.
    Larsen R; Ryder LP; Svejgaard A; Gniadecki R
    Clin Exp Immunol; 2007 Jul; 149(1):23-30. PubMed ID: 17403057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion.
    Franssen ME; Smit JV; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 2003 Sep; 149(3):506-12. PubMed ID: 14510982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
    Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
    J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T cell subsets in psoriasis.
    Kagen M; Cao LY; Oyetakin-White P; Tacastacas JD; Yan C; McCormick TS; Cooper KD
    Photodermatol Photoimmunol Photomed; 2012 Dec; 28(6):293-8. PubMed ID: 23126290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer and natural killer-T cells in psoriasis.
    Cameron AL; Kirby B; Fei W; Griffiths CE
    Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
    Horroccks A; Ormerod AD; Duncan JI; Thomson AW
    Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.